Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

582
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
582
Drug Therapy01:28

Drug Therapy

423
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
423
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

400
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
400
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

327
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
327
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

802
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
802
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

488
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
488

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Benign Prostatic Hyperplasia in Older Adults.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2016
Same author

Introduction: pharmacy practice has changed.

Journal of pharmacy practice·2014
Same author

Providing medication therapy management for smoking cessation patients.

Journal of pharmacy practice·2014
Same author

Role of medication therapy management in preexposure prophylaxis therapy for HIV prevention.

Journal of pharmacy practice·2014
Same author

Improving patient safety--improving lives: a patient's story.

Journal of health care for the poor and underserved·2009
Same journal

Aripiprazole and Unexpected Salivation: A Case of Drug-Induced Sialorrhea Refractory to Anticholinergics.

Journal of pharmacy practice·2026
Same journal

Exploring Strategies to Educate Reproductive-Aged Individuals About Pharmacist-Prescribed Hormonal Contraception in Indiana: A Qualitative Study.

Journal of pharmacy practice·2026
Same journal

Assessing Kansas Pharmacy Preceptors' Experiences, Knowledge, and Attitudes Toward Pharmacogenomics.

Journal of pharmacy practice·2026
Same journal

The Impact of Academic Detailing on Clinician and Patient Outcomes: A Narrative Review.

Journal of pharmacy practice·2026
Same journal

Management of a Kratom and Tianeptine Overdose.

Journal of pharmacy practice·2026
Same journal

Strategies for Substituting ADHD Medications During Stimulant Shortages.

Journal of pharmacy practice·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
12:19

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

17

Preparing to provide MTM services.

Zandra M Glenn1, Soheyla L Mahdavian2, Todd J Woodard3

  • 1Econometrica Inc, Bethseda, MD, USA zglenn@econometricainc.com.

Journal of Pharmacy Practice
|December 28, 2014
PubMed
Summary
This summary is machine-generated.

Medication Therapy Management (MTM) enhances pharmacists' roles in healthcare. Addressing reimbursement challenges is key for pharmacists to fully contribute to patient care and improve health outcomes.

Keywords:
Collaboration Practice AgreementsMedication Therapy Managementhealth carereimbursement

More Related Videos

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

1.0K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
12:19

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

17
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

1.0K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K

Area of Science:

  • Pharmacy practice and healthcare policy
  • Clinical outcomes research
  • Health economics

Background:

  • The US healthcare system faces pressure for improved clinical and economic outcomes.
  • Pharmacists are increasingly recognized as integral members of the healthcare team.
  • The Medicare Modernization Act of 2003 acknowledged pharmacists' expertise in managing patient medication therapy.

Purpose of the Study:

  • To explore the evolving role of pharmacists in healthcare.
  • To examine the significance of Medication Therapy Management (MTM) and Collaboration Practice Agreements (CPA).
  • To identify challenges, particularly reimbursement, faced by pharmacists providing MTM services.

Main Methods:

  • Review of healthcare policy and professional practice guidelines.
  • Analysis of the impact of MTM and CPA on pharmacist roles.
  • Examination of economic factors influencing pharmacist service provision.

Main Results:

  • MTM programs and CPA are expanding the pharmacist's role in patient care.
  • Pharmacists possess unique expertise to identify and resolve medication therapy problems.
  • Reimbursement for pharmacist-provided services remains a significant barrier.

Conclusions:

  • Pharmacists are essential for optimizing patient medication therapy and improving health outcomes.
  • Policy and practice changes are needed to ensure adequate reimbursement for MTM services.
  • Further integration of pharmacists into multidisciplinary teams can enhance healthcare delivery.